Click to go to DrugInjuryLaw Home


Legal information and news about prescription drug side effects
NuvaRing Case Evaluation Ortho Evra Case Evaluation Fosamax Case Evaluation Avandia Case EvaluationKetek Case Evaluation Zelnorm Case Evaluation Meridia Case Evaluation Zocor Case Evaluation
Vytorin Case EvaluationZetia Case Evaluation Yasmin Case Evaluation Ocella Case EvaluationYAZ Case Evaluation Levaquin Case Evaluation Byetta Case Evaluation Gianvi Case Evaluation


Free Case Evaluation

Crestor Information

What is Crestor?

Crestor® (rosuvastatin) is a statin drug used to lower cholesterol by inhibiting production of an enzyme in the liver, much like the recalled drug Baycol. Crestor is uniquely distinguished from the other five statins on the market because of its potential for kidney toxicity. During clinical trials, patients taking the 80 mg dose of Crestor began to show signs of muscle weakness, early symptoms of rhabdomyolysis, and kidney damage, and the 80 mg dose was discontinued.

Crestor Side Effects Double Those of Other Statins
A new analysis of post-marketing safety reports suggests that patients using Crestor (rosuvastatin) are more likely to develop serious side effects than patients taking Lipitor (atorvastatin), Zocor (simvastatin), or Pravachol (pravastatin).


Crestor Should be Used as Last Resort
FDA Official and UK Medicine Regulators Expressed Worries Over Crestor. In the US, the FDA's Dr. David Graham cautions that AstraZeneca's cholesterol-lowering drug Crestor should only be used after all other alternatives have failed.


Crestor May Harm Kidneys
Crestor is linked to increased incidences of rhabdomyolysis and the rate of kidney damage in Crestor patients is 75 times higher than in patients taking other cholesterol drugs.


Crestor Should be Taken Off the Market
Public Citizen Letter in Lancet Journal Warns that Crestor is Dangerous


Crestor Dear Doctor Letter Sent to UK Doctors
New rhabdomyolysis cases prompt AstraZeneca to caution doctors to prescribe lowest dose of Crestor initially.


Crestor Warning
ADVISORY - Health Canada Advising Canadians About a Possible Association Between Crestor and Rhabdomyolysis


Free Crestor Case Evaluation

Drug Injury Watch: Crestor News Commentary


  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • DrugInjuryLaw.com is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535
email: ThomasJLamb@DrugInjuryLaw.com

Disclaimer